Montreux is focused on investments in the pharmaceutical and medical device industries. The Firm seeks opportunities where its breadth and depth of experience can be of direct value to its portfolio companies. The Firm's portfolio companies typically possess the following key features:

• Focus on therapeutic products
• Large, innovative, commercially attractive markets
• Minimized safety risk
• Demonstration of efficacy "Proof of Concept"
• A well understood path to FDA approval
• Management teams with comprehensive experience and a capital efficient approach

Montreux typically invests in the first institutional capital raising of its portfolio companies. We invest in clinical and commercialization stage companies.

Montreux seeks to lead or actively invest in syndicates with experienced and like-minded investors that are dedicated to financing companies to important value creation inflection points in a capital efficient manner.

Montreux applies a rigorous screening process to identify those companies with the best potential for generating superior financial returns for our limited partners. Our investment process begins with a thorough understanding of a candidate company's technology, products, and markets. The Firm also conducts a diligent examination of the backgrounds and talents of the management team.

Once an investment is made, our role is to support a company's management in executing on its business by participating as an active member of the company's board of directors. We work proactively and collaboratively to build the executive team, facilitate relationships with other companies, help set the company's strategic direction, and assist in future financings and liquidity options.